Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.
New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly ...
Human rights, key and vulnerable populations Ethiopia received PEPFAR funding for work on stigma, discrimination and enabling legal environments. As a result of the USG stop-work order, all programmes ...
AllAfrica on MSN10h
CS Barasa Flags Off ARV Consignment, Assures of Uninterrupted HIV CareHealth Cabinet Secretary Deborah Barasa has reaffirmed Kenya's dedication to providing uninterrupted care for individuals living with HIV, despite recent challenges stemming from a freeze in foreign ...
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and ...
Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...
AllAfrica on MSN16h
Journalists Trained in Ethical Reporting to Boost HIV/Aids AwarenessAccurate and ethical journalism on HIV/AIDS plays a vital role in shaping public perceptions, encouraging behavioral change, and raising awareness. Misinformation or vague reporting, however, can ...
The collection of public health surveillance data has always reflected ideas about individual rights.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback